EP Patent

EP2435582A1 — miRNA BIOMARKERS FOR THE DIAGNOSIS OF DUCHENNE MUSCULAR DYSTROPHY, ITS PROGRESSION AND FOR MONITORING THERAPEUTIC INTERVENTIONS

Assigned to Universita degli Studi di Roma La Sapienza · Expires 2012-04-04 · 14y expired

What this patent protects

The invention refers to diagnosis and therapy of muscle degenerative disorders, as Duchenne Muscular Dystrophy (DMD) by means of a class of specific miRNAs.

USPTO Abstract

The invention refers to diagnosis and therapy of muscle degenerative disorders, as Duchenne Muscular Dystrophy (DMD) by means of a class of specific miRNAs.

Drugs covered by this patent

Patent Metadata

Patent number
EP2435582A1
Jurisdiction
EP
Classification
—
Expires
2012-04-04
Drug substance claim
No
Drug product claim
No
Assignee
Universita degli Studi di Roma La Sapienza
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.